Acquisition of Private Biotechnology Company
In a securities case filed in the state of California, shareholders of a privately held biotechnology company brought suit against a pharmaceutical company that had acquired the biotechnology company in…
Average Wholesale Price Litigation
Cornerstone Research has worked with counsel for several pharmaceutical companies on state False Claims Act cases alleging that these companies caused state Medicaid agencies to overpay for prescription drugs by…
Bard Peripheral Vascular, Inc. v. W.L. Gore & Associates, Inc.
In 1984 W.L. Gore & Associates (Gore) obtained an option from Bard Peripheral Vascular (Bard) to license any patent resulting from a patent application that issued in 2002 as the…
Biotechnology Manufacturing Agreement
A U.S. company that owned a patented biotechnology product engaged a European contractor to produce the product for commercial sale.
Biotechnology Monopolization Class Action
Counsel for a biotechnology firm retained Cornerstone Research in a class action monopolization case.
Biotechnology Shareholder Breach of Fiduciary Duty
Minority shareholders in a financially troubled biotechnology company alleged that the majority shareholder drove the company’s choices of funding sources and that the interests of minority shareholders were not properly…
Cancer Therapies
The owner of a patent for technology employed in the manufacture of a drug used in certain cancer therapies alleged that the pharmaceutical company that developed and manufactured the drug…
Commercial Success
In the liability phase of a pharmaceutical patent infringement lawsuit, the branded drug manufacturer may offer evidence of commercial success that flows from the patent to support a finding of…
Commercially Reasonable Efforts
Counsel for a biopharmaceutical company retained Cornerstone Research to address claims being arbitrated that it had breached a contractual obligation by failing to use diligent and commercially reasonable efforts to…
Cost Shifting
Cost shifting refers to the practice of increasing the price or markup charged to one group of patients in response to a decrease in another group’s price or markup.
How can we help you?
If you are looking for a publication not on our website, contact us.